{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:49:18Z","timestamp":1787064558085,"version":"build-2736575974"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/mop.0b013e32833fde3f","type":"journal-article","created":{"date-parts":[[2010,9,24]],"date-time":"2010-09-24T13:16:13Z","timestamp":1285334173000},"page":"745-750","source":"Crossref","is-referenced-by-count":110,"title":["Update on diagnosis, treatment, and prognosis in opsoclonus\u2013myoclonus\u2013ataxia syndrome"],"prefix":"10.1097","volume":"22","author":[{"given":"Mark P","family":"Gorman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210206","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/WCO.0b013e3280126b51","article-title":"An update on opsoclonus","volume":"20","author":"Wong","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"R2-12-20210206","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"R3-12-20210206","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejpn.2009.03.002","article-title":"A prospective study of the presentation and management of dancing eye syndrome\/opsoclonus-myoclonus syndrome in the United Kingdom","volume":"14","author":"Pang","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"key":"R4-12-20210206","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1177\/0009922808330882","article-title":"Ataxia without opsoclonus: right lumbar sympathetic trunk neuroblastoma","volume":"48","author":"Herman","year":"2009","journal-title":"Clin Pediatr"},{"key":"R5-12-20210206","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejpn.2009.12.005","article-title":"Opsoclonus-myoclonus in children associated or not with neuroblastoma.","volume":"14","author":"Krug","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"key":"R6-12-20210206","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/1043454204272560","article-title":"Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome","volume":"22","author":"Tate","year":"2005","journal-title":"J Pediatr Oncol Nurs"},{"key":"R7-12-20210206","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/adc.2009.160044","article-title":"Opsoclonus myoclonus: a nonepileptic movement disorder that may present as status epilepticus","volume":"94","author":"Haden","year":"2009","journal-title":"Arch Dis Child"},{"key":"R8-12-20210206","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.canlet.2005.01.051","article-title":"Opsoclonus myoclonus syndrome in neuroblastoma: a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy","volume":"228","author":"Matthay","year":"2005","journal-title":"Cancer Lett"},{"key":"R9-12-20210206","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00381-009-0979-3","article-title":"Neurological complications of neuroblastic tumors: experience of a single center","volume":"26","author":"Aydin","year":"2010","journal-title":"Childs Nerv Syst"},{"key":"R10-12-20210206","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1542\/peds.2004-2377","article-title":"Longitudinal neurodevelopmental evaluation of children with opsoclonus-ataxia","volume":"116","author":"Mitchell","year":"2005","journal-title":"Pediatrics"},{"key":"R11-12-20210206","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00431-006-0247-4","article-title":"Long-term outcome of ten children with opsoclonus-myoclonus syndrome","volume":"166","author":"Klein","year":"2007","journal-title":"Eur J Pediatr"},{"key":"R12-12-20210206","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/pbc.22226","article-title":"Improvement of neurological status and quality of life in children with opsoclonus myoclonus syndrome at long-term follow-up","volume":"53","author":"Catsman-Berrevoets","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R13-12-20210206","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00431-009-1048-3","article-title":"Mycoplasma pneumoniae associated opsoclonus-myoclonus syndrome in three cases","volume":"169","author":"Huber","year":"2010","journal-title":"Eur J Pediatr"},{"key":"R14-12-20210206","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1002\/mds.22832","article-title":"Opsoclonus myoclonus syndrome in the context of Salmonellosis","volume":"24","author":"Flabeau","year":"2009","journal-title":"Mov Disord"},{"key":"R15-12-20210206","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1212\/01.wnl.0000262766.50747.27","article-title":"Opsoclonus-myoclonus syndrome associated with cytomegalovirus encephalitis","volume":"68","author":"Zaganas","year":"2007","journal-title":"Neurology"},{"key":"R16-12-20210206","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1177\/0883073807307086","article-title":"Human herpesvirus 6 rhombencephalitis in immunocompetent children","volume":"22","author":"Crawford","year":"2007","journal-title":"J Child Neurol"},{"key":"R17-12-20210206","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.pediatrneurol.2010.02.009","article-title":"Opsoclonus-myoclonus syndrome attributable to hepatitis C infection","volume":"42","author":"Ertekin","year":"2010","journal-title":"Pediatr Neurol"},{"key":"R18-12-20210206","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-0029-1237723","article-title":"Long-term follow-up of neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome","volume":"40","author":"De Grandis","year":"2009","journal-title":"Neuropediatrics"},{"key":"R19-12-20210206","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jneuroim.2008.05.033","article-title":"Autoantibodies in childhood opsoclonus-myoclonus syndrome.","volume":"201-","author":"Blaes","year":"2008","journal-title":"J Neuroimmunol"},{"key":"R20-12-20210206","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jneuroim.2007.01.006","article-title":"IgG subclass distribution of autoantibodies in pediatric opsoclonus-myoclonus syndrome","volume":"185","author":"Beck","year":"2007","journal-title":"J Neuroimmunol"},{"key":"R21-12-20210206","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1196\/annals.1423.027","article-title":"New autoantibodies in pediatric opsoclonus myoclonus syndrome","volume":"1110","author":"Kirsten","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"R22-12-20210206","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1001\/archneurol.2009.299","article-title":"Opsoclonus-myoclonus syndrome in anti-N-methyl-D-aspartate receptor encephalitis","volume":"67","author":"Kurian","year":"2010","journal-title":"Arch Neurol"},{"key":"R23-12-20210206","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/mds.20125","article-title":"CSF B-cell expansion in opsoclonus-myoclonus syndrome: a biomarker of disease activity","volume":"19","author":"Pranzatelli","year":"2004","journal-title":"Mov Disord"},{"key":"R24-12-20210206","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1055\/s-2007-985906","article-title":"Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus-myoclonus syndrome (OMS)","volume":"38","author":"Krasenbrink","year":"2007","journal-title":"Neuropediatrics"},{"key":"R25-12-20210206","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1212\/01.wnl.0000313840.27060.bf","article-title":"Invited article: inhibition of B cell functions \u2013 implications for neurology","volume":"70","author":"Dalakas","year":"2008","journal-title":"Neurology"},{"key":"R26-12-20210206","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2009.03.006","article-title":"Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome","volume":"210","author":"Fuhlhuber","year":"2009","journal-title":"J Neuroimmunol"},{"key":"R27-12-20210206","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cyto.2008.06.001","article-title":"Therapeutic down-regulation of central and peripheral B-cell-activating factor (BAFF) production in pediatric opsoclonus-myoclonus syndrome","volume":"44","author":"Pranzatelli","year":"2008","journal-title":"Cytokine"},{"key":"R28-12-20210206","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejpn.2009.04.011","article-title":"Dancing eye syndrome associated with spontaneous recovery and normal neurodevelopment","volume":"14","author":"Ki Pang","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"key":"R29-12-20210206","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0022-3468(89)80291-X","article-title":"Clinical outcome in children with acute cerebellar encephalopathy and neuroblastoma","volume":"24","author":"Telander","year":"1989","journal-title":"J Pediatr Surg"},{"key":"R30-12-20210206","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/088307389000500217","article-title":"Opsoclonus-ataxia due to childhood neural crest tumors: a chronic neurologic syndrome","volume":"5","author":"Mitchell","year":"1990","journal-title":"J Child Neurol"},{"key":"R31-12-20210206","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0022-3476(06)80167-8","article-title":"Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma","volume":"125","author":"Koh","year":"1994","journal-title":"J Pediatr"},{"key":"R32-12-20210206","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0887-8994(95)00083-R","article-title":"Outcome of children with opsoclonus-myoclonus regardless of etiology","volume":"13","author":"Hammer","year":"1995","journal-title":"Pediatr Neurol"},{"key":"R33-12-20210206","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF01953945","article-title":"Neurological sequelae of the dancing eye syndrome","volume":"155","author":"Pohl","year":"1996","journal-title":"Eur J Pediatr"},{"key":"R34-12-20210206","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/(SICI)1096-911X(199704)28:4<284::AID-MPO7>3.0.CO;2-E","article-title":"Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group","volume":"28","author":"Russo","year":"1997","journal-title":"Med Pediatr Oncol"},{"key":"R35-12-20210206","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1067\/mpd.2001.118200","article-title":"Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and antineuronal antibodies","volume":"139","author":"Hayward","year":"2001","journal-title":"J Pediatr"},{"key":"R36-12-20210206","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/mpo.1138","article-title":"Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies: a report from the Children's Cancer Group Study","volume":"36","author":"Rudnick","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"R37-12-20210206","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1542\/peds.109.1.86","article-title":"Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae","volume":"109","author":"Mitchell","year":"2002","journal-title":"Pediatrics"},{"key":"R38-12-20210206","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pediatrneurol.2004.03.008","article-title":"Neuropsychological outcome after acute disseminated encephalomyelitis: impact of age at illness onset","volume":"31","author":"Jacobs","year":"2004","journal-title":"Pediatr Neurol"},{"key":"R39-12-20210206","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1212\/01.WNL.0000158474.24191.BC","article-title":"Cognitive functioning in children and adolescents with multiple sclerosis","volume":"64","author":"MacAllister","year":"2005","journal-title":"Neurology"},{"key":"R40-12-20210206","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1055\/s-2006-955931","article-title":"High dose pulsatile dexamethasone therapy in children with opsoclonus-myoclonus syndrome","volume":"37","author":"Rostasy","year":"2006","journal-title":"Neuropediatrics"},{"key":"R41-12-20210206","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/pbc.21107","article-title":"Treatment of neuroblastoma-related opsoclonus-myoclonus-ataxia syndrome with high-dose dexamethasone pulses","volume":"50","author":"Ertle","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R42-12-20210206","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/mds.22941","article-title":"B cell depletion therapy for new-onset opsoclonus-myoclonus","volume":"25","author":"Pranzatelli","year":"2010","journal-title":"Mov Disord"},{"key":"R43-12-20210206","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejpn.2007.05.005","article-title":"Chronic relapsing opsoclonus-myoclonus syndrome: combination of cyclophosphamide and dexamethasone pulses","volume":"12","author":"Wilken","year":"2008","journal-title":"Eur J Paediatr Neurol"},{"key":"R44-12-20210206","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00002826-200111000-00007","article-title":"Controlled pilot study of piracetam for pediatric opsoclonus-myoclonus","volume":"24","author":"Pranzatelli","year":"2001","journal-title":"Clin Neuropharmacol"},{"key":"R45-12-20210206","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10875-009-9335-3","article-title":"Long-term cerebrospinal fluid and blood lymphocyte dynamics after rituximab for pediatric opsoclonus-myoclonus","volume":"30","author":"Pranzatelli","year":"2010","journal-title":"J Clin Immunol"},{"key":"R46-12-20210206","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/0883073808324217","article-title":"Insights on chronic-relapsing opsoclonus-myoclonus from a pilot study of mycophenolate mofetil","volume":"24","author":"Pranzatelli","year":"2009","journal-title":"J Child Neurol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0b013e32833fde3f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T20:43:14Z","timestamp":1740516194000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201012000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e32833fde3f","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}